Adrián Gil-Korilis

Adrián Gil-Korilis

Auto-generated profile, based on publicly available information

Adrián Gil-Korilis

Department of Endocrinology and Nutrition, Institute of Nutrition and Health, Clínica Universidad de Navarra, Pamplona, Spain

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2023 in Applied Clay Science
Verified
Journal Article
Open access
AGAdrián Gil-Korilis
Adrián Gil-Korilis
MCMihail Cojocaru
Mihail Cojocaru
MBMelibea Berzosa
Melibea Berzosa
CGCarlos Gamazo
Carlos Gamazo
NANatália J. Andrade
Natália J. Andrade
KCKatia Ciuffi
Katia Ciuffi

23 March 2026 in Journal of Diabetes and its Complications
Verified
Journal Article
Open access
CPCarolina M. Perdomo
Carolina M. Perdomo
AGAdrián Gil-Korilis
Adrián Gil-Korilis
MZMarta Zaballos
Marta Zaballos
IVIsabela Valdés-Calero
Isabela Valdés-Calero
JNJorge M. Núñez-Córdoba
Jorge M. Núñez-Córdoba
JEJavier Escalada
Javier Escalada
Ultrasound is a cost-effective tool for characterizing abdominal fat, with measurement accuracy comparable to advanced imaging techniques. A lack of standard operating procedures has hindered widespread adoption. Our study aimed to describe, through ultrasound, the adipose tissue layers of the abdominal wall in patients living with excess body fat. Cross-sectional study including 103 adults. Patients with a healthy fat mass were excluded. Fat mass was quantified through Clínica Universidad de Navarra-Body Adiposity Estimator (CUN-BAE). Ultrasound was performed at the midpoint between the xiphoid process and the navel (1-3 cm above the umbilicus) along the linea alba. Mean age (SD) was 46.6 (14.4) years, and 74.8% were women. A subcutaneous adipose tissue (SAT) measurement >1.8 cm showed significantly higher adiposity indices (BMI, CUN-BAE), systolic blood pressure, and laboratory metabolic parameters (insulin, HOMA-IR, triglycerides, creatinine) than those with SAT ≤1.8 cm. SAT was associated with an increased prevalence of dysglycemia (Q4 vs. Q1, adjusted OR 6.13; 95% CI 1.38-27.28), showing strong discriminative ability (AUC = 0.79; 95% CI 0.69-0.89). In a primary care setting, ultrasound characterization of abdominal fat should include measurement of the SAT maximum layer above the navel along the linea alba, as it may aid in evaluating metabolic risk.

21 February 2026 in Molecular Medicine
Verified
Journal Article
Open access
PDF file
AGAdrián Gil-Korilis
Adrián Gil-Korilis
JEJorge Ergui-Arbizu
Jorge Ergui-Arbizu
PHPetr Hanak
Petr Hanak
NDNatálie Danešová
Natálie Danešová
KTKristyna Tomasova
Kristyna Tomasova
SVSona Vodenkova
Sona Vodenkova
Background: Telomere shortening and mitochondrial dysfunction are well-known independent contributors to many diseases, but emerging evidence suggests a reciprocal relationship between the two processes. The role of the so-called telomere-mitochondrial axis in colorectal cancer (CRC) remains largely unknown. Methods: This prospective cohort study screened CRC patients who underwent surgery, from whom peripheral blood, intestinal mucosa, and tumor samples were collected. Colonoscopically confirmed cancer- and adenoma-free healthy individuals were screened as controls, from whom peripheral blood and intestinal mucosa samples were obtained. Relative mitochondrial DNA copy number (mtDNA-CN) and relative telomere length (RTL) were measured in all samples by real-time quantitative polymerase chain reaction and were further compared and correlated considering clinical data. Relative mtDNA-CN was quantified using both TaqMan probes and SYBR Green to compare both methods. Finally, multivariable analyses were conducted to investigate the association between both biomarkers and the risk of tumor recurrence and mortality. Results: A total of 166 CRC patients and 61 healthy individuals were included in the study. In TNM stage I patients, relative mtDNA-CN and RTL were negatively correlated with each other in intestinal mucosa (ρ = -0.77, p < 0.0001), tumor tissue (ρ = -0.41, p = 0.032), and the tumor-to-intestinal mucosa ratio (ρ = -0.39, p = 0.046). However, these associations disappeared with increasing TNM stage, suggesting a dysregulation of the telomere-mitochondrial axis in advanced disease. Higher relative mtDNA-CN in blood was associated with a lower risk of disease recurrence even after adjusting for multiple covariates (HR = 0.43, 95% CI 0.20–0.97, p = 0.041), highlighting its potential use as a prognostic tool. The quantification of mtDNA-CN performed by both methods -TaqMan probes and SYBR Green- was shown to be positively correlated ( p < 0.01). Relative mtDNA-CN and RTL were found to be tissue-dependent in both CRC patients and healthy controls. Conclusions: This study provides a novel contribution to the understanding of the almost unexplored telomere-mitochondrial axis in CRC, highlighting its potential role in disease progression and prognosis. Graphical Created with https://www.BioRender.com .

19 August 2024 in Bioactivities
Verified
Journal Article
Open access
AGAdrián Gil-Korilis
Adrián Gil-Korilis
JEJorge Ergui-Arbizu
Jorge Ergui-Arbizu
Silver nanoparticles (AgNPs) are known for their broad scientific and technological applications, among which those related to their bioactivity stand out the most. Its antimicrobial, antioxidant, anti-inflammatory, anti-obesity, antifouling, and biosorption properties have been widely studied and analyzed. Furthermore, numerous strategies are being investigated to overcome the main limitation of AgNPs, their cytotoxicity, such as the development of green chemistry synthesis methods using plant extracts or the use of support materials for controlled release of nanoparticles. However, the methodologies currently used in this line of research limit these nanomaterials from eventually being used in the clinic. It is necessary to implement animal models and interdisciplinary collaboration with biomedical research groups to develop therapies based on AgNPs that may be able to have an impact on the health of patients.

26 December 2023 in Anales del Sistema Sanitario de Navarra
Verified
Journal Article
Open access
AGAdrián Gil-Korilis
Adrián Gil-Korilis
CEClaudia Esquíroz-Patiño
Claudia Esquíroz-Patiño
ALAroa Llamas-Llamazares
Aroa Llamas-Llamazares
RMRebeca Manrique
Rebeca Manrique
IDInes Diaz-Dorronsoro
Ines Diaz-Dorronsoro
Masses and cysts in the heart are well-known entities, but their low prevalence and non-specific symptoms makes the diagnosis difficult. We aimed to characterize the features of these entities in our environment. We carried out a search of patients who underwent surgery for tumors and cysts in the heart between 2002 and 2022 in the registry of the Department of Cardiology and Cardiac Surgery of Clínica Universidad de Navarra (Pamplona, Spain). Sociodemographic, clinical, histological, and surgical variables were collected. We identified 13 patients; mean age was 63.08 ± 15.17 years, 76.92% were female and 92.31% had at least one cardiovascular risk factor, e.g., BMI = 25 kg/m2 and high blood pressure (61.54% and 53.85%, respectively). The most common type of cardiac tumors were myxomas (69.23%). Around half (46.15%) were incidental; the most frequent symptom was dyspnea (53.85%); 30.77% of the patients were asymptomatic. The most commonly used imaging technique for the diagnosis was transthoracic Doppler echocardiography (69.23%). The agreement between the mean diameters before and after surgery was very high (ICC = 0.807, 95% CI: 0.450 - 0.943). We describe the features of masses and cysts in the heart (77% female patients) and provide information scarcely available in the literature, e.g., the most frequent cardiovascular risk factors for this population. A case of cardiac leiomyosarcoma and a case of intimal sarcoma of the pulmonary trunk are described, two extremely rare tumors for which there are few described cases.